-+ 0.00%
-+ 0.00%
-+ 0.00%

Compass Therapeutics Abstract Accepted For Oral Presentation At Upcoming European Society For Medical Oncology Congress

Benzinga·07/17/2026 14:47:13
Listen to the news

Compass Therapeutics, Inc. (NASDAQ:CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that its abstract titled "A randomized trial of paclitaxel ± tovecimig in previously treated patients with advanced biliary tract cancer" has been accepted for an oral Proffered Paper presentation at the upcoming European Society for Medical Oncology (ESMO) Congress. The congress will take place October 23-27, 2026 in Madrid, Spain.